PrEP After 50: HIV Prevention for Older Gay Men
Most PrEP marketing is aimed at men in their twenties and thirties, which leaves a lot of gay and bisexual men over 50 quietly wondering whether it still applies to them, whether their doctor will bring it up, and whether the pill fits alongside the blood-pressure medication, the statin, and the occasional ibuprofen. The short answer is that PrEP works the same at 55 as it does at 25. What changes is the monitoring, the medication list you need to reconcile, and — after 65 — how it gets paid for.
The short version
- HIV doesn't age out. CDC data show people aged 45 and older accounted for roughly one in five new HIV diagnoses in 2022, and NIH notes about 16% of new diagnoses were in people 50 and older. Gay and bisexual men still account for about two-thirds of all new diagnoses.
- There is no upper age limit for PrEP in CDC's guideline. The one age-specific rule: once you're 50 or older, CDC calls for a kidney check at least every 6 months on the oral pills, instead of yearly.
- The oral options differ mainly in their kidney and bone footprint. Truvada (TDF) needs an estimated creatinine clearance of 60 or better to start; Descovy (TAF) can be used down to 30. The injectables — Apretude and Yeztugo — have no kidney threshold and no routine kidney monitoring.
- The interactions that matter at this age are mostly about the kidneys (regular high-dose NSAIDs plus TDF) and, for twice-yearly lenacapavir, about drugs it can raise the levels of — including sildenafil, tadalafil, simvastatin, and lovastatin.
- Since September 30, 2024, Medicare covers PrEP under Part B with no cost sharing — the drug, up to eight HIV tests a year, and up to eight counseling visits a year.
Is HIV still a real risk after 50?
Yes, and the numbers are more stubborn than most people assume. CDC's surveillance data for 2022 put 12% of new HIV diagnoses in people aged 45–54, 8% in people 55–64, and 2% in people 65 and older — about 22% combined, or roughly 8,300 people in a single year. NIH's HIVinfo summary of the same CDC data says adults 50 and older made up about 16% of new diagnoses, and that more than half of all people living with HIV in the U.S. are now over 50. Male-to-male sexual contact remained the transmission category for about 67% of all new diagnoses.
The rate is lower than in men in their twenties, and it's fair to say so. But older men carry a distinct disadvantage that the raw rate hides: they are more likely to be diagnosed late. NIH lists the reasons plainly — clinicians often don't think to offer testing to older patients, early symptoms get blamed on ageing, and many older adults are embarrassed to ask. A man who acquires HIV at 58 and isn't tested until he's sick has lost years of treatment. PrEP, with its built-in quarterly HIV test, is as much a testing program as a prevention program, and that alone is a reason many older men stay on it.
The kidney rule: why 50 changes your lab schedule
CDC's PrEP guideline has exactly one recommendation that keys off age, and it's about your kidneys. Tenofovir — the shared ingredient in Truvada and Descovy — is cleared by the kidneys and, in the TDF form especially, can stress them. So the guideline says: check estimated creatinine clearance before starting, then at least every 12 months for most people, but at least every 6 months if you're 50 or older or if your clearance was under 90 mL/min when you began. The New York State AIDS Institute guideline goes further and treats age over 40, high blood pressure, and diabetes as reasons for closer monitoring.
The thresholds to start are the other half of this. CDC sets the floor for TDF-based PrEP at an estimated creatinine clearance of 60 mL/min or higher, and for TAF-based Descovy at 30 or higher. Kidney function declines gradually with normal ageing, and conditions that cluster after 50 — hypertension, diabetes, years of NSAID use — push it down faster. Plenty of men in their sixties still clear the 60 bar comfortably; some don't, and for them Descovy or an injectable is the natural fit rather than a reason to skip PrEP.
One practical note: the standard kidney estimate is calculated from serum creatinine, which also rises with muscle mass. If you're on testosterone therapy, that can muddy the number — we cover that overlap separately.
Bones: less of an issue than it sounds
TDF-based PrEP causes a small drop in bone mineral density, and that word "bone" understandably lands harder at 60 than at 30. The evidence is reassuring, with limits. The New York State guideline summarizes it this way: bone density losses with TDF/FTC as PrEP are minimal, have not been linked to fractures, and are reversible in adults 20 and older. CDC's own guidance only raises bone density as a specific concern for adolescents, and does not recommend routine bone scans for adults on PrEP. The DISCOVER trial that compared Descovy with Truvada found small but statistically significant differences in kidney and bone lab markers favoring Descovy — but no difference in actual clinical outcomes.
The honest caveat is that the PrEP trials weren't built to study men who already have osteopenia or osteoporosis, or who are on long-term steroids. If that's you, it doesn't rule out PrEP; it's a reason to mention it at the visit, because the choice between TDF, TAF, and an injectable is easy to make in your favor once your clinician knows.
Your other medications: the interactions worth checking
By 50, most men are on something. The good news is that the oral PrEP pills have very few true drug interactions, because tenofovir and emtricitabine are cleared by the kidneys rather than processed by the liver enzymes that handle most other drugs. Statins, blood-pressure medications, metformin, antidepressants, and erectile-dysfunction pills are not flagged as interactions with Truvada or Descovy. A few things do deserve attention:
- NSAIDs and other kidney-cleared drugs. CDC's guidance says to co-administer oral PrEP with care alongside other drugs eliminated by the kidneys, and specifically names high-dose or multiple NSAIDs, along with acyclovir/valacyclovir and a handful of less common antivirals. The University of Liverpool interaction checker rates ibuprofen with TDF/FTC as unstudied but notes it may reduce tenofovir's clearance, with the concern being prolonged use or pre-existing kidney trouble. An occasional ibuprofen is not the problem; daily naproxen for arthritis on top of TDF is worth a conversation, and possibly a switch to Descovy or an injectable.
- Valacyclovir for herpes suppression is on that same kidney-cleared list. It's a common combination and usually fine — it just means your kidney labs matter a little more.
- Lenacapavir (Yeztugo) is the one that touches your other prescriptions. Its prescribing information describes it as a moderate inhibitor of the liver enzyme CYP3A, which means it can raise blood levels of drugs metabolized that way. HIV i-Base's patient guide lists sildenafil, tadalafil, and vardenafil, plus simvastatin and lovastatin, among the drugs that may need dose adjustment. Gilead's interaction summary reports no clinically significant interaction with atorvastatin, rosuvastatin, or pitavastatin. The catch: because the injection lasts six months, that effect can persist for up to nine months after your last shot. In the other direction, strong enzyme inducers — rifampin, carbamazepine, phenytoin, St John's wort — can lower lenacapavir to unprotective levels.
None of this makes any PrEP option off-limits for an older man. It makes the medication list the most important thing you bring to the visit.
The injectables: sometimes the simplest answer
For a lot of older men, the cleanest option is to sidestep the kidney and bone questions entirely. Cabotegravir (Apretude, a shot every two months) and lenacapavir (Yeztugo, twice a year) have no creatinine-clearance threshold to start and no routine kidney monitoring on CDC's schedule. Neither is metabolized in a way that stresses the kidneys, and neither has a bone signal. Apretude in particular has essentially no interaction concerns beyond the same enzyme inducers that affect lenacapavir. For a man with borderline kidney function, arthritis he treats with NSAIDs, or simply a pill organizer that's already full, an injection every two or six months is often the better-tolerated choice — and it removes the daily-adherence question, which matters more the more medications you juggle.
The trade-off is logistics: a clinic visit for each injection, and the long "tail" after stopping, during which CDC recommends bridging with oral PrEP and continued HIV testing if you're still at risk. We walk through the switch step by step here.
Paying for it after 65: Medicare finally covers PrEP
This was the biggest practical barrier for older men until recently, and it has largely been removed. On September 30, 2024, the Centers for Medicare & Medicaid Services issued a national coverage determination that moves PrEP into Medicare Part B as a preventive service. According to the AAFP's summary of that decision, Medicare now covers FDA-approved oral and injectable PrEP with no cost sharing, plus up to eight HIV screening tests every 12 months, up to eight individual counseling visits every 12 months, and a one-time hepatitis B screening. Your clinician's assessment of your history is what establishes eligibility — there is no age cutoff.
Two caveats. The move from Part D to Part B changed how pharmacies bill, and the HIV+Hepatitis Policy Institute warned that the lack of a transition period could cause prescription hiccups — if a pharmacy says PrEP "isn't covered," that's usually a billing-pathway problem, not a coverage one. And labs beyond the covered HIV and hepatitis B tests, like kidney function, are billed as ordinary Part B services, so a small cost is possible depending on your supplemental coverage. Under 65, the picture is the same as for everyone else: most private plans must cover PrEP at no cost under the USPSTF "A" grade, and our cost guide covers the assistance programs if you're uninsured.
STIs don't retire either
PrEP prevents HIV and nothing else, and STIs are climbing fastest in exactly this age group: CDC data reported by NBC News show that between 2012 and 2022, syphilis cases among adults 55 and older rose roughly seven-fold and gonorrhea nearly five-fold — from a low base, but no rounding error. Older men on PrEP get the same quarterly-to-twice-yearly syphilis, gonorrhea, and chlamydia screening CDC recommends for everyone on PrEP — and the same access to DoxyPEP, the after-sex doxycycline dose that cut bacterial STIs substantially in the trials of gay and bisexual men and transgender women. CDC's DoxyPEP guidance has no age ceiling. Doxycycline's own considerations for older adults are the ordinary ones: take it with water and stay upright to protect the esophagus, and be aware of sun sensitivity. If you take an antacid, calcium, iron, or magnesium supplement, separate it from the doxycycline dose by a couple of hours, since those minerals block its absorption.
When to talk to a clinician
Starting PrEP after 50 is routine, but it goes better when your prescriber sees the whole picture. Bring a complete medication list — including supplements and anything for erectile dysfunction — and raise it specifically if you have known kidney disease or a creatinine clearance that's ever come back under 60; if you take NSAIDs most days; if you've been told you have osteopenia or osteoporosis; if you're on testosterone; or if you're on Medicare and unsure how the new coverage applies to you. If your primary-care doctor has never asked about your sex life, that's not a reason to go without PrEP — it's a reason to bring it up yourself, or to use a service built for exactly this. Our reviewing clinical team prescribes PrEP by telehealth and is used to working around a full medication list; the $25/month membership covers visits and lab coordination, and you can book a visit directly.
The bottom line
PrEP works just as well at 65 as at 25, CDC's guideline sets no upper age limit, and Medicare now pays for it. What age changes is the housekeeping: a kidney check every six months instead of every year on the pills, a closer look at the medication list, and a real conversation about whether Descovy or an injectable suits you better than Truvada. Older gay men are diagnosed later and treated later than younger men. Being on PrEP — with its built-in testing — is one of the more effective ways to make sure that doesn't happen to you.